Consumer biomarker-testing kits (like 23andme, and the equivalents for whole-genome sequencing, proteomics, microbiome, etc) don't make a ton of practical sense to me as a path towards new medical treatments.
-
Show this thread
-
For the most part, we don't yet *know* which genes and other biomarkers are predictive of which diseases. So these kits are of limited practical value except in the occasional case of a disease with a well-known genetic component.
1 reply 0 retweets 2 likesShow this thread -
Replying to @razibkhan
I don't doubt that useful info is *in* the data!
0 replies 0 retweets 0 likes -
Replying to @razibkhan
Usable in the sense of "objectively a good predictor" is a hell of a long way from usable in the sense of "doctors and insurers will trust it." Which means that your market has to be scientifically literate, which is a small # of people.
0 replies 0 retweets 0 likes
Replying to @razibkhan
Didn't know that about medical geneticists pushing PRS's; good to hear!
2:42 PM - 18 Apr 2019
0 replies
0 retweets
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.